Transplantation Proceedings
Volume 31, Issue 3, Supplement 1 , Pages 25S-30S, May 1999

Cyclosporine: the case for expanding bioequivalence criteria to include measures of individual bioequivalence in relevant population subsets

  • W.H Barr

      Affiliations

    • Department of Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia, USA
    • Corresponding Author InformationAddress reprint requests to William H. Barr, PharmD, PhD, E.C. Robins Professor and Chair, Department of Pharmaceutics, Virginia Commonwealth University, 410 N 12th St, Smith Bldg, Room 454, Richmond, VA 23219

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0041-1345(99)00110-4

Transplantation Proceedings
Volume 31, Issue 3, Supplement 1 , Pages 25S-30S, May 1999

Article Tools

* Image Usage & Resolution